12 June 2018
Pfizer Canada’s support of the NEOMED Institute will accelerate the commercialization of new drugs resulting from scientific discoveries at universities.
This contribution will also strengthen the ties between private companies, universities and research centres, to better meet the needs of patients, which is a goal of the Quebec Life Sciences Strategy.
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies.
The NEOMED Institute is a not-for-profit organization whose mission is to enable and accelerate the commercialization of life science discoveries.
Please complete this form